Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression. - Binkley, N.; Silverman, S. L.; Simonelli, C.; Santiago, N.; Kohles, J. D.; Dasic, G.; Sunyecz, J. A. (Osteoporosis International, 2009)